Chemoradiotherapy: Clinical Trials

7 trials for Chemoradiotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 not yet recruiting, 2 recruiting. 7 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable7Unknown 3, Not yet recruiting 2, Recruiting 2

Follow Chemoradiotherapy: new trials by email Literature Review of Chemoradiotherapy trials Research Report on Chemoradiotherapy

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Application of Intelligent Care Systems in Radiation Therapy: Enhancing Patient Safety and Reducing Anxiety Through System Optimization and Real-Time Blood Data Monitoring
Real-Time Blood Data Monitoring System (Device/Software Integration), Enhanced Patient Education Materials (Behavioral/Educational Intervention), Internal Warning Signs and Alerts (Behavioral Intervention) - Radiation Therapy, Chemoradiotherapy
Not applicableNot yet recruitingChung Shan Medical University1002025-02-202025-02-20
Toripalimab Combined With Definitive CCRT for LACC Patients
Toripalimab, CCRT - Cervical Cancer, Chemoradiotherapy
Not applicableRecruitingRuijin Hospital1502024-02-022024-04-24
Upfront Resection of Locally Advanced NSCLC Followed by Chemoradiotherapy
Upfront resection - Locally Advanced Non-Small Cell Lung Cancer, Chemoradiotherapy
Not applicableUnknownThe Netherlands Cancer Institute202023-04-012023-03-20
Prehabilitation in Rectal Cancer: During Neoadjuvant Therapy vs Preoperative
prehabilitation - Rectal Cancer, Adenocarcinoma, Chemoradiotherapy
Not applicableUnknownCorporacion Parc Tauli502022-03-012022-03-18
Chemoradiotherapy Sequenced Radical Surgery for Colorectal Cancer With PALNM
Radical surgery with PALND, Radical surgery without PALND - Colorectal Neoplasms Malignant, Lymph Node Excision
Not applicableNot yet recruitingQilu Hospital of Shandong University402022-01-012021-11-22
Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer
Hydrochloride anlotinib, cis Platinum/carboplatin, External beam radiotherapy and brachytherapy - Uterine Cervical Neoplasms, Chemoradiotherapy
Not applicableUnknownZhongnan Hospital532021-03-122022-05-18
Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)
Paclitaxel plus carboplatin, radiotherapy - Esophageal Squamous Cell Carcinoma, Chemoradiotherapy
Not applicableRecruitingFudan University3202020-01-062021-11-02

Narrower conditions

Uterine Cervical Neoplasms (2)  ·  Anxiety Disorders (1)  ·  Colonic Neoplasms (1)  ·  Esophageal Squamous Cell Carcinoma (1)  ·  Rectal Neoplasms (1)

Broader conditions

Neoplasms (5)  ·  Neoplasms by Site (5)  ·  Digestive System Diseases (3)  ·  Digestive System Neoplasms (3)  ·  Gastrointestinal Diseases (3)  ·  Gastrointestinal Neoplasms (3)  ·  Colorectal Neoplasms (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Neoplasms, Female (2)  ·  Intestinal Diseases (2)  ·  Intestinal Neoplasms (2)  ·  Urogenital Diseases (2)

Interventions

Carboplatin (2)  ·  Behavior Therapy (1)  ·  Brachytherapy (1)  ·  Caffeine (1)  ·  Cisplatin (1)  ·  Paclitaxel (1)  ·  Preoperative Exercise (1)  ·  Radiotherapy (1)  ·  toripalimab (1)

Sponsors

Chung Shan Medical University (1)  ·  Corporacion Parc Tauli (1)  ·  Fudan University (1)  ·  Qilu Hospital of Shandong University (1)  ·  Ruijin Hospital (1)  ·  The Netherlands Cancer Institute (1)  ·  Zhongnan Hospital (1)

Countries

China (4)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Haoping Xu (1)  ·  Hui Qiu, Ph. D. (1)  ·  Koen Hartemink, MD, PhD (1)  ·  Kuaile Zhao, doctor (1)  ·  Laura Mora, Dr (1)  ·  Xiangpeng Zheng, doctor (1)

Results publications

PMID 23008766, PMID 23058059, PMID 25629513, PMID 27536795, PMID 30025745, PMID 33505914